List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 142 studies with search of: "Dacarbazine"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed
Has Results 		Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant Melanoma
Condition: Malignant Melanoma
Interventions: Biological: Dacarbazine + Interferon alpha + Thymosin-alpha-1 1.6 mg;   Biological: Dacarbazine + Interferon alpha + Thymosin-alpha-1 3.2 mg;   Biological: Dacarbazine + Interferon alpha + Thymosin-alpha-1 6.4 mg;   Biological: Dacarbazine + Thymosin-alpha-1 3.2 mg;   Drug: Dacarbazine + Interferon alpha
2 Active, not recruiting Trial of Dacarbazine With or Without Genasense in Advanced Melanoma
Condition: Melanoma
Interventions: Drug: dacarbazine plus Genasense;   Drug: dacarbazine plus placebo
3 Active, not recruiting Dacarbazine and Ipilimumab vs. Dacarbazine With Placebo in Untreated Unresectable Stage III or IV Melanoma
Condition: Melanoma
Interventions: Drug: Ipilimumab and Dacarbazine;   Drug: Placebo and Dacarbazine
4 Recruiting A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma
Condition: Malignant Melanoma
Interventions: Drug: ABI-007;   Drug: Dacarbazine
5 Recruiting Safety Study of Combined Chemotherapy and Endostar to Untreated Patients With Advanced Melanoma
Conditions: Advanced Melanoma;   Untreated Patients
Interventions: Drug: dacarbazine plus Endostar (Experimental group);   Drug: dacarbazine plus placebo (control group)
6 Active, not recruiting Trial of PI-88 With Dacarbazine in Patients With Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: PI-88 and dacarbazine;   Drug: dacarbazine or DTIC
7 Active, not recruiting Imatinib in Combination With Dacarbazine and Capecitabine in Medullary Thyroid Carcinoma
Conditions: Solid Tumor;   Thyroid Cancer
Interventions: Drug: Capecitabine (Xeloda);   Drug: DTIC-Dome (Dacarbazine);   Drug: Gleevec (Imatinib Mesylate)
8 Completed
Has Results 		Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267AM2)(COMPLETED)
Condition: Melanoma
Interventions: Drug: Temozolomide;   Drug: Dacarbazine
9 Recruiting Adjuvant, Combined Interleukin 2 (Proleukin) and DTIC (Dacarbazine) in High-Risk Melanoma Patients
Condition: Metastatic Melanoma
Intervention: Drug: Proleukin and Dacarbazine
10 Recruiting Safety Study of Dacarbazine and Bortezomib in Melanoma and Soft Tissue Sarcoma
Conditions: Melanoma;   Soft Tissue Sarcoma;   Parathyroid Carcinoma;   Small Cell Carcinoma of the Lung;   Carcinoid Tumors
Intervention: Drug: Dacarbazine and bortezomib
11 Terminated A Phase I/II Study of Sunitinib and Dacarbazine
Condition: Melanoma
Interventions: Drug: Sunitinib;   Drug: Dacarbazine
12 Recruiting Sorafenib and Dacarbazine in Soft Tissue Sarcoma
Conditions: Sarcoma;   Synovial Sarcoma;   Leiomyosarcoma;   Malignant Peripheral Nerve Sheath Tumor
Intervention: Drug: Sorafenib and Dacarbazine
13 Recruiting Comparison of AZD6244 in Combination With Dacarbazine Versus (vs) Dacarbazine Alone in BRAF Mutation Positive Melanoma Patients
Condition: Melanoma
Interventions: Drug: AZD2644;   Drug: Dacarbazine
14 Completed A Study to Assess the Safety and Pharmacokinetics of an Inhibitor of PARP in Combination With Dacarbazine
Condition: Melanoma Neoplasms
Interventions: Drug: KU-0059436 (AZD2281)(PARP inhibitor);   Drug: dacarbazine
15 Completed Lenalidomide and Dacarbazine (DTIC) in Patients With Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: Lenalidomide;   Drug: Dacarbazine
16 Recruiting A Phase I/II Study of Dasatinib and Dacarbazine
Condition: Metastatic Melanoma
Intervention: Drug: Dasatinib and Dacarbazine
17 Recruiting Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma
Condition: Sarcoma
Intervention: Drug: dacarbazine
18 Completed Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma
Conditions: Stage IV Melanoma;   Stage III Melanoma;   Recurrent Melanoma
Interventions: Drug: allovectin-7;   Drug: allovectin-7/dacarbazine;   Drug: dacarbazine
19 Active, not recruiting Safety Study of IMC-1121B With or Without Dacarbazine to Treat Metastatic Malignant Melanoma
Condition: Metastatic Malignant Melanoma
Interventions: Biological: IMC-1121;   Drug: Dacarbazine
20 Active, not recruiting Dacarbazine With or Without Oblimersen (G3139) in Treating Patients With Advanced Malignant Melanoma
Condition: Melanoma (Skin)
Interventions: Biological: oblimersen sodium;   Drug: dacarbazine

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services